Leptin and obesity: All in the head?

October 10, 2001

In the absence of leptin signaling, mice, like humans, grow extremely obese and develop many of the common sequellae of obesity in humans, such as diabetes and steatosis of the liver. Introduction of leptin directly into the hypothalamus potently reverses the overeating and obesity seen in leptin-deficient animals. Still, expression of the leptin receptor ObR is not limited to the hypothalamus and other regions of the brain, but also occurs in the liver and many other sites. Hence, the possibility remains that some of aspects of the leptin-deficient phenotype reflect the absence of peripheral signaling. To test the significance of various sites of central and peripheral leptin signaling, Cohen et al. have used Cre-lox technology to generate mice in which particular cell types delete the ObR gene by somatic recombination. Here, they describe the effects of ObR deficiency in the brain or the liver. Absence of neuronal ObR greatly increases body weight and induces the accumulation of fat in the liver, effects that are not seen when the ObR defect is restricted to the liver. Because obesity in the brain-specific knockout is not as severe as that in simple knockouts, it may be that OBR signaling in organs helps regulate energy homeostasis?effects that may still be revealed in other Cre/lox experiments . However, the authors note that there was considerable scatter in their data and that those animals that had most efficiently removed the ObR gene from their neurons weighed the most. The complete absence of neuronal ObR might, if it could be achieved using this technology, might therefore recapitulate all of the effects observed in Ob- or ObR-deficient animals.

JCI Journals

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.